|
Legendary
|
|
Join Date: Sep 2006
Posts: 10,984
|
|
|
Legendary
Join Date: Sep 2006
Posts: 10,984
|
http://www.eurekalert.org/pub_releas...-gta092707.php
Genetic test announced for suicidal ideation in patients using antidepressant drugs
Safer prescribing anticipated
Quote:
|
Boulder, CO, October 1, 2007 – NeuroMark, a Boulder, Colorado company, announced today the immediate availability of a genetic test to identify people at risk of suicidal ideation—thoughts of committing suicide—when prescribed an antidepressant drug. The test, called the Mark-C™ test, is expected to help restore public confidence in antidepressant medication and help to reduce a recently announced spike in suicide rates among U.S. youth. “This is an exciting example of the power of genetics to address a critical need and make important drugs safer for patients worldwide,” stated Kim Bechthold, NeuroMark’s CEO
|
Watch this space...
http://www.neuromark.com/
|